Houston, TX USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

TJP1 Protein May Identify Multiple Myeloma Patients Most Likely to Benefit From Proteasome Inhibitors

A gene known as TJP1 (tight junction protein 1) could help determine which multiple myeloma patients would best benefit from proteasome inhibitors such as bortezomib, as well as combination approaches to enhance proteasome inhibitor sensitivity,...
28-Apr-2016 12:00 PM EDT Add to Favorites

MD Anderson and Helsinn Healthcare SA Enter Strategic Alliance to Improve Life of Patients Conducting Clinical Studies in Cancer Supportive and Palliative Care

The University of Texas MD Anderson Cancer Center and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care, today announced that they signed a strategic alliance on a broad, multi-years program of clinical studies in cancer...
26-Apr-2016 8:00 AM EDT Add to Favorites

Teen Cancer Patients and Their Families Get ‘Red Carpet’ Ready for a Special Prom

The University of Texas MD Anderson Children’s Cancer Hospital, in collaboration with local restaurants and businesses, will host a special prom for its pediatric cancer patients on Saturday, April 30 from 5 p.m. to 9 p.m.
25-Apr-2016 10:05 AM EDT Add to Favorites

Cancer, Meet Your Match: Andrew Sabin Family Fellows Announced


Eight of The University of Texas MD Anderson Cancer Center’s top young researchers today were formally named Andrew Sabin Family Fellows at an event honoring their benefactor, Andrew Sabin, and representatives of the Andrew Sabin Family...
21-Apr-2016 12:00 PM EDT Add to Favorites

Monitoring Sugar Metabolism in Liver May Be a Key to Cancer Diagnosis


Scientists may have discovered a significant new diagnostic marker for liver cancer, according to a paper published in the April 18 online issue of Nature Cell Biology.
18-Apr-2016 11:05 AM EDT Add to Favorites

First Computer Program Developed to Detect DNA Mutations in Single Cancer Cells


Researchers at The University of Texas MD Anderson Cancer Center have announced a new method for detecting DNA mutations in a single cancer cell versus current technology that analyzes millions of cells which they believe could have important...
18-Apr-2016 11:05 AM EDT Add to Favorites

Study Drug LOXO-101 Shows Tumor Regression in Varied Cancers


A phase I study of the drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined cancer, according to a study led by The University of Texas MD Anderson Cancer Center.
17-Apr-2016 5:15 PM EDT Add to Favorites

First-Ever Nivolumab Study to Treat Aggressive Anal Cancer Appears Promising


A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
15-Apr-2016 5:30 PM EDT Add to Favorites

Our Experts on Newswise

MD Anderson Study Reveals New Insight Into Tumor Progression


Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6


A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System


The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

The HPV Vaccine: What Have We Learned?

Expert at The University of Texas M. D. Anderson Cancer Center provide insight to parents based on what we've learned about about the HPV vaccine in the past four years.
12-Jan-2010 3:45 PM EST

M. D. Anderson Offers Guidance on Choosing Tobacco Cessation Products

Whether you smoke three cigarettes or three packs of cigarettes a day, kicking the habit is difficult. Various nicotine replacement products are on the market to make quitting easier. But which product is right for you? Experts from The University...
11-Nov-2009 4:15 PM EST

Our YouTube Videos